Posts Tagged events

Obamacare’s Here to Stay. What Do Business Leaders – TodayHeads

Friday, June 29th, 2012 | Permalink

Long before the Supreme Court ruling that upheld the Patient Protection and Affordable Health Care Act, the political battle lines appeared pretty clear. With lobbies like the National Federation of Independent Business (NFIB) acting as plaintiffs in the case, it was easy to assume the business community was solidly aligned in the “against” category on Obamacare, too.

But business reaction has been more mixed, even at the small business level.  After all, the legislation addresses much more than the question of whether individuals should be forced to have health insurance. The June 28 decision also upheld a 2.3 percent tax on the revenue of medical device companies. And it offers intellectual property protection that was considered critical by many in the biotechnology sector. So while some see the specter of higher costs, others salivate at the prospect of a wider insured pool that spurs demand for everything from broader hospital services to more mobile health apps.

View article:
Obamacare’s Here to Stay. What Do Business Leaders – TodayHeads

WHO Compendium 2011 of New and Emerging Health Technologies

Sunday, March 11th, 2012 | Permalink

XING Google Group Twitter RSS … CSC Announces Pocket Health iPhone App · Dell Simplifies Sharing, Management and Retention of Medical Imaging Data for UK Hospitals · GE, Microsoft Share Plans for New Joint Venture, Caradigm · Industry Supports European Commission in Strengthening Medical Devices Legislation · Medway is First to Implement Advanced Health & Care’s Advanced Community System · Agfa HealthCare at ECR 2012 · Web-Based Support …

Read the original post:
WHO Compendium 2011 of New and Emerging Health Technologies

MDMA Statement on House MDUFA Hearing

Wednesday, February 15th, 2012 | Permalink

Wed, 02/15/2012 FDA WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the House Energy and Commerce Subcommittee on Health hearing entitled “Reauthorization of MDUFA: What it Means for Jobs, Innovation and Patients:”  “MDMA appreciates all of the House Subcommittee’s work on the important issue of medical device innovation. read more

Visit link:
MDMA Statement on House MDUFA Hearing

Dr Margaret Chan nominated for a second term to be WHO Director-General

Wednesday, January 18th, 2012 | Permalink

18 January 2012 — Dr Margaret Chan was nominated today by the WHOs Executive Board for a second term as Director-General of the Organization. If confirmed by the World Health Assembly, Dr Chan’s new term will begin on 1 July 2012 and continue until 30 June 2017.

Read More:
Dr Margaret Chan nominated for a second term to be WHO Director-General

Executive Board appoints the Regional Director for the WHO Eastern Mediterranean Region

Tuesday, January 17th, 2012 | Permalink

17 January 2012 — Dr Ala Alwan will take up his appointment as the Regional Director of WHO’s Eastern Mediterranean Region (WHO/EMRO) for a five-year term starting on 1 February 2012.

Read More:
Executive Board appoints the Regional Director for the WHO Eastern Mediterranean Region